Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Observational evidence from patients diagnosed with chronic lymphocytic leukaemia (CLL) in Finland between 2005-2015 show improved survival over time.

Lindström V, Hakkarainen KM, Mehtälä J, Klement R, Leval A, Järvinen TM.

Eur J Haematol. 2019 Sep;103(3):190-199. doi: 10.1111/ejh.13273. Epub 2019 Jul 25.

PMID:
31210368
2.

On-scalp MEG system utilizing an actively shielded array of optically-pumped magnetometers.

Iivanainen J, Zetter R, Grön M, Hakkarainen K, Parkkonen L.

Neuroimage. 2019 Jul 1;194:244-258. doi: 10.1016/j.neuroimage.2019.03.022. Epub 2019 Mar 15.

3.

Simulated Encounters With Vaccine-Hesitant Parents: Arts-Based Video Scenario and a Writing Exercise.

Koski K, Lehto JT, Hakkarainen K.

J Med Educ Curric Dev. 2018 Aug 2;5:2382120518790257. doi: 10.1177/2382120518790257. eCollection 2018 Jan-Dec.

4.

Neural activity patterns between different executive tasks are more similar in adulthood than in adolescence.

Moisala M, Salmela V, Carlson S, Salmela-Aro K, Lonka K, Hakkarainen K, Alho K.

Brain Behav. 2018 Sep;8(9):e01063. doi: 10.1002/brb3.1063. Epub 2018 Jul 26.

5.

Comparing Methods for Estimating Direct Costs of Adverse Drug Events.

Gyllensten H, Jönsson AK, Hakkarainen KM, Svensson S, Hägg S, Rehnberg C.

Value Health. 2017 Dec;20(10):1299-1310. doi: 10.1016/j.jval.2017.06.007. Epub 2017 Jul 25.

6.

Undergraduate curriculum in palliative medicine at Tampere University increases students' knowledge.

Lehto JT, Hakkarainen K, Kellokumpu-Lehtinen PL, Saarto T.

BMC Palliat Care. 2017 Jan 25;16(1):13. doi: 10.1186/s12904-016-0182-8.

7.

Direct and indirect costs for adverse drug events identified in medical records across care levels, and their distribution among payers.

Natanaelsson J, Hakkarainen KM, Hägg S, Andersson Sundell K, Petzold M, Rehnberg C, Jönsson AK, Gyllensten H.

Res Social Adm Pharm. 2017 Nov;13(6):1151-1158. doi: 10.1016/j.sapharm.2016.11.008. Epub 2016 Nov 19.

PMID:
27894838
8.

Gaming is related to enhanced working memory performance and task-related cortical activity.

Moisala M, Salmela V, Hietajärvi L, Carlson S, Vuontela V, Lonka K, Hakkarainen K, Salmela-Aro K, Alho K.

Brain Res. 2017 Jan 15;1655:204-215. doi: 10.1016/j.brainres.2016.10.027. Epub 2016 Nov 2.

PMID:
27815094
9.

The Dark Side of Internet Use: Two Longitudinal Studies of Excessive Internet Use, Depressive Symptoms, School Burnout and Engagement Among Finnish Early and Late Adolescents.

Salmela-Aro K, Upadyaya K, Hakkarainen K, Lonka K, Alho K.

J Youth Adolesc. 2017 Feb;46(2):343-357. doi: 10.1007/s10964-016-0494-2. Epub 2016 May 2.

PMID:
27138172
10.

Media multitasking is associated with distractibility and increased prefrontal activity in adolescents and young adults.

Moisala M, Salmela V, Hietajärvi L, Salo E, Carlson S, Salonen O, Lonka K, Hakkarainen K, Salmela-Aro K, Alho K.

Neuroimage. 2016 Jul 1;134:113-121. doi: 10.1016/j.neuroimage.2016.04.011. Epub 2016 Apr 8.

PMID:
27063068
11.

Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study.

Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Petzold M, Hägg S.

Eur J Clin Pharmacol. 2015 Dec;71(12):1525-33. doi: 10.1007/s00228-015-1950-8. Epub 2015 Sep 26.

12.

Adherence to Antihypertensive Therapy and Elevated Blood Pressure: Should We Consider the Use of Multiple Medications?

Hedna K, Hakkarainen KM, Gyllensten H, Jönsson AK, Andersson Sundell K, Petzold M, Hägg S.

PLoS One. 2015 Sep 11;10(9):e0137451. doi: 10.1371/journal.pone.0137451. eCollection 2015.

13.

Pharmacoepidemiology at Nordic School of Public Health NHV: Examples from 1999 to 2014.

Stålsby Lundborg C, Gyllensten H, Hedna K, Hakkarainen KM, Lesén E, Andersson Sundell K, Gyllensten H, Hedna K, Hakkarainen KM, Lesén E, Sundell KA.

Scand J Public Health. 2015 Aug;43(16 Suppl):73-80. doi: 10.1177/1403494814568600.

PMID:
26311803
14.

Discrepancies in expert decision-making in forensic fingerprint examination.

Mustonen V, Hakkarainen K, Tuunainen J, Pohjola P.

Forensic Sci Int. 2015 Sep;254:215-26. doi: 10.1016/j.forsciint.2015.07.031. Epub 2015 Jul 29.

PMID:
26254629
15.

The impact of a changed legislation on reporting of adverse drug reactions in Sweden, with focus on nurses' reporting.

Karlsson SA, Jacobsson I, Boman MD, Hakkarainen KM, Lövborg H, Hägg S, Jönsson AK.

Eur J Clin Pharmacol. 2015 May;71(5):631-6. doi: 10.1007/s00228-015-1839-6. Epub 2015 Apr 7.

16.

Expertise among professional magicians: an interview study.

Rissanen O, Pitkänen P, Juvonen A, Kuhn G, Hakkarainen K.

Front Psychol. 2014 Dec 23;5:1484. doi: 10.3389/fpsyg.2014.01484. eCollection 2014.

17.

Economic impact of adverse drug events--a retrospective population-based cohort study of 4970 adults.

Gyllensten H, Hakkarainen KM, Hägg S, Carlsten A, Petzold M, Rehnberg C, Jönsson AK.

PLoS One. 2014 Mar 17;9(3):e92061. doi: 10.1371/journal.pone.0092061. eCollection 2014.

18.

Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults.

Hakkarainen KM, Gyllensten H, Jönsson AK, Andersson Sundell K, Petzold M, Hägg S.

Br J Clin Pharmacol. 2014 Jul;78(1):170-83. doi: 10.1111/bcp.12314.

19.

Refill adherence and self-reported adverse drug reactions and sub-therapeutic effects: a population-based study.

Hedna K, Hägg S, Andersson Sundell K, Petzold M, Hakkarainen KM.

Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1317-25. doi: 10.1002/pds.3528. Epub 2013 Oct 11.

20.

Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

PLoS One. 2013 Sep 4;8(9):e73166. doi: 10.1371/journal.pone.0073166. eCollection 2013.

21.

Modelling drug-related morbidity in Sweden using an expert panel of pharmacists'.

Gyllensten H, Hakkarainen KM, Jönsson AK, Andersson Sundell K, Hägg S, Rehnberg C, Carlsten A.

Int J Clin Pharm. 2012 Aug;34(4):538-46. doi: 10.1007/s11096-012-9641-3. Epub 2012 Apr 28.

PMID:
22544221
22.

Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions--a meta-analysis.

Hakkarainen KM, Hedna K, Petzold M, Hägg S.

PLoS One. 2012;7(3):e33236. doi: 10.1371/journal.pone.0033236. Epub 2012 Mar 15.

23.

Modelling drug-related morbidity in Sweden using an expert panel of physicians.

Hakkarainen KM, Alström D, Hägg S, Carlsten A, Gyllensten H.

Eur J Clin Pharmacol. 2012 Sep;68(9):1309-19. doi: 10.1007/s00228-012-1244-3. Epub 2012 Mar 6.

24.

Methods for assessing the preventability of adverse drug events: a systematic review.

Hakkarainen KM, Andersson Sundell K, Petzold M, Hägg S.

Drug Saf. 2012 Feb 1;35(2):105-26. doi: 10.2165/11596570-000000000-00000. Review.

25.

Curriculum reform in Finnish pharmacy education.

Katajavuori N, Hakkarainen K, Kuosa T, Airaksinen M, Hirvonen J, Holm Y.

Am J Pharm Educ. 2009 Dec 17;73(8):151.

26.

Preventable drug related mortality in a Swedish population.

Jönsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hägg S.

Pharmacoepidemiol Drug Saf. 2010 Feb;19(2):211-5. doi: 10.1002/pds.1890.

PMID:
19998370
27.

[Integration of disciplines in medicine promotes learning and definition of the core content of the program].

Hakkarainen K, Pasternack A.

Duodecim. 2005;121(6):633-9. Review. Finnish. No abstract available.

PMID:
15907088
28.

[The integration of teaching medicine in Finland by medical faculties].

Hakkarainen K, Suonpää J.

Duodecim. 2004;120(21):2577-81. Finnish. No abstract available.

PMID:
15631414
29.

Anaemia in the first but not in the second or third trimester is a risk factor for low birth weight.

Hämäläinen H, Hakkarainen K, Heinonen S.

Clin Nutr. 2003 Jun;22(3):271-5.

PMID:
12765667
30.

[Assessment of the information gathered during basic medical education].

Hakkarainen K, Koivisto AM, Laippala P, Puhakka H, Pasternack A.

Duodecim. 2000;116(13):1375-80. Finnish. No abstract available.

PMID:
12001360
31.

Naturally occurring human autoantibodies recognize a fetal brain antigen identified as microtubulus associated protein 1B.

Peltola J, Hellman J, Hakkarainen K, Marttinen A, Soppi E, Molnara GK.

Life Sci. 2002 Jan 11;70(8):887-92.

PMID:
11853226
32.

DNA vaccination in mice using HIV-1 nef, rev and tat genes in self-replicating pBN-vector.

Tähtinen M, Strengell M, Collings A, Pitkänen J, Kjerrström A, Hakkarainen K, Peterson P, Kohleisen B, Wahren B, Ranki A, Ustav M, Krohn K.

Vaccine. 2001 Feb 28;19(15-16):2039-47.

PMID:
11228375
33.

Humoral and cellular immune responses to HIV-1 nef in mice DNA-immunised with non-replicating or self-replicating expression vectors.

Collings A, Pitkänen J, Strengell M, Tähtinen M, Lagerstedt A, Hakkarainen K, Ovod V, Sutter G, Ustav M, Ustav E, Männik A, Ranki A, Peterson P, Krohn K.

Vaccine. 1999 Oct 14;18(5-6):460-7.

PMID:
10519935
34.

Dietary vitamin E effect on color stability and sensory assessment of spoilage in three beef muscles.

Chan WK, Hakkarainen K, Faustman C, Schaefer DM, Scheller KK, Liu Q.

Meat Sci. 1996 Apr;42(4):387-99.

PMID:
22060889
35.

Circulating autoantibodies to a 240 kD fetal brain protein.

Peltola JT, Hakkarainen K, Marttinen A, Soppi E, Molnar GK.

Life Sci. 1996;58(6):519-23.

PMID:
8569425
36.

Effect of mutations in rev gene of SIVmac on virus replication.

Aavik E, Hakkarainen K, Krohn KJ.

AIDS Res Hum Retroviruses. 1994;10 Suppl 2:S123-8.

PMID:
7865286
37.

Comparison of three serological methods for diagnosing Mycoplasma pneumoniae infection.

Karppelin M, Hakkarainen K, Kleemola M, Miettinen A.

J Clin Pathol. 1993 Dec;46(12):1120-3.

38.

Evidence of previous infection with Mycobacterium avium-Mycobacterium intracellulare complex among healthy subjects: an international study of dominant mycobacterial skin test reactions.

von Reyn CF, Barber TW, Arbeit RD, Sox CH, O'Connor GT, Brindle RJ, Gilks CF, Hakkarainen K, Ranki A, Bartholomew C, et al.

J Infect Dis. 1993 Dec;168(6):1553-8.

PMID:
8245545
39.

Transcomplementation of simian immunodeficiency virus Rev with human T-cell leukemia virus type I Rex.

Krohn KJ, Hakkarainen K, Aavik E, Dewhurst S, Sadaie R, Mullins JI.

J Virol. 1993 Sep;67(9):5681-4.

40.
41.

Clinical scoring system in the evaluation of adult pharyngitis.

Seppälä H, Lahtonen R, Ziegler T, Meurman O, Hakkarainen K, Miettinen A, Arstila P, Eskola J, Saikku P, Huovinen P.

Arch Otolaryngol Head Neck Surg. 1993 Mar;119(3):288-91.

PMID:
8435167
42.

Chronic lung disease of preterm infants in Finland is not associated with Ureaplasma urealyticum colonization.

Saxén H, Hakkarainen K, Pohjavuori M, Miettinen A.

Acta Paediatr. 1993 Feb;82(2):198-201.

PMID:
8477168
43.

Serological responses to mycoplasmas in HIV-infected and non-infected individuals.

Hakkarainen K, Jansson E, Ranki A, Valle SL, Krohn KJ.

AIDS. 1992 Nov;6(11):1287-92.

PMID:
1472333
44.

Mycoplasmas and arthritis.

Hakkarainen K, Turunen H, Miettinen A, Karppelin M, Kaitila K, Jansson E.

Ann Rheum Dis. 1992 Oct;51(10):1170-2. Review. No abstract available.

45.

[Renewed occurrence of Mycoplasma].

Hakkarainen K, Miettinen A, Turunen H, Luotola K, Karppelin M, Kaitila K, Jansson E.

Duodecim. 1992;108(12):1092-4. Review. Finnish. No abstract available.

PMID:
1366059
46.

Mycoplasmas and human arthritis.

Jansson E, Hakkarainen K, Miettinen A, Kaitila K, Karppelin M.

Ann Rheum Dis. 1991 Jul;50(7):527. No abstract available.

47.

Mycoplasmas and leukaemia.

Jansson E, Wegelius R, Hakkarainen K, Miettinen A.

Res Virol. 1991 Jul-Aug;142(4):333. No abstract available.

PMID:
1796218
48.

Oral mucosal soft tissue necrosis caused by superinfection. Report of three cases.

Helovuo H, Forssell K, Hakkarainen K.

Oral Surg Oral Med Oral Pathol. 1991 May;71(5):543-8.

PMID:
2047093
49.
50.

Pharyngitis in adults: the presence and coexistence of viruses and bacterial organisms.

Huovinen P, Lahtonen R, Ziegler T, Meurman O, Hakkarainen K, Miettinen A, Arstila P, Eskola J, Saikku P.

Ann Intern Med. 1989 Apr 15;110(8):612-6.

PMID:
2494921

Supplemental Content

Loading ...
Support Center